Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
Pamela Blair AllenAshley A McCook-VealJeffrey M SwitchenkoDarina M PaulinoTim NiyogusabaKatelin M BairdErica S TarabadkarMary Jo LechowiczPublished in: Cancer (2022)
Staging and baseline laboratory assessments with imaging, peripheral blood flow cytometry, TCR data, and LDH in patients who have newly diagnosed MF may identify those who are at risk for progression to advanced stage.
Keyphrases
- newly diagnosed
- lymph node
- flow cytometry
- peripheral blood
- end stage renal disease
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- high resolution
- neoadjuvant chemotherapy
- regulatory t cells
- machine learning
- genome wide
- big data
- early stage
- patient reported outcomes
- mass spectrometry
- patient reported